文献速递生殖医学

人卵原干细胞体外分化为卵母细胞样细胞:单细胞分离与分子特征鉴定

In vitro differentiation of human oocyte-like cells from oogonial stem cells: single-cell isolation and molecular characterization.
PubMed 文献 · Hum Reprod · 2018-01-01

研究从19例绝经后和13例绝经前女性卵巢皮质分离DDX4阳性卵原干细胞(OSC),培养3周后经单细胞分离获得大型卵母细胞样细胞,表达GDF-9和SYCP3并进入减数分裂,FISH显示单倍体。绝经前女性OSC数量较高,但两组大型卵母细胞样细胞比例无显著差异。

要点

  • 绝经前女性DDX4阳性OSC中SSEA-4+和FRAGILIS+亚群均值高于绝经后女性。
  • 培养后两组均产生大型单倍体卵母细胞样细胞,表达GDF-9和SYCP3。
  • 卵巢皮质DDX4阳性细胞数与年龄呈负相关,分化率低,干细胞微环境作用不能排除。

核心结论

  • 在适当培养条件下,来自绝经前和绝经后女性卵巢皮质的DDX4阳性OSC可分化为表达GDF-9和SYCP3并进入减数分裂的大型单倍体卵母细胞样细胞。
  • 由于分化率低,不能排除干细胞微环境对OSC分化的重要作用。

研究设计与样本

  • 从19例绝经后和13例绝经前女性(因子宫肌瘤、卵巢囊肿或其他良性病变行子宫切除术)获取卵巢皮质,分离DDX4阳性OSC并培养最多3周。
  • 培养3周后基于PKH26红色染色和细胞大小用DEPArray单细胞分离大型卵母细胞样细胞,用微滴数字PCR检测GDF-9、SYCP3和DPPA3,用FISH检测X和5号染色体倍性。

主要发现

  • DDX4阳性群体中SSEA-4+亚群均值在绝经后女性为46.7%、绝经前女性为64.9%,FRAGILIS+亚群均值在绝经后女性为47.5%、绝经前女性为64.8(P < 0.05)。
  • 女性年龄与卵巢皮质每cm3中DDX4阳性细胞比例呈负相关(P < 0.05)。
  • 培养后两组均形成大型(可达80 μm)成熟卵母细胞样细胞,绝经前女性培养中这些细胞数量较高(37.4 vs 23.7/孔;P < 0.001),但培养内大型卵母细胞样细胞百分比在两组间无显著差异。
  • 来自绝经前和绝经后女性的单个大型卵母细胞样细胞表达等效水平的GDF-9 mRNA(分别为2.0和2.6拷贝/μl RNA)和SYCP3 mRNA(分别为1.2和1.5拷贝/μl RNA)。
  • 剩余小细胞表达大量DPPA3 mRNA(绝经后和绝经前女性分别为5.0和5.1拷贝/μl RNA),大型卵母细胞样细胞中检测不到;FISH显示大型细胞X和5号染色体各一个信号(单倍体),小细胞各两个信号(二倍体)。

局限性

  • 研究证明了从成年女性卵巢皮质收集的OSC可分化为卵母细胞样细胞,但由于分化率低,不能排除干细胞微环境的重要作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are the large cells derived from cultured DEAD box polypeptide 4 (DDX4)-positive oogonial stem cells (OSCs), isolated from the ovarian cortex of non-menopausal and menopausal women, oocyte-like cells? SUMMARY ANSWER: Under appropriate culture conditions, DDX4-positive OSCs from non-menopausal and menopausal women differentiate into large haploid oocyte-like cells expressing the major oocyte markers growth differentiation factor 9 (GDF-9) and synaptonemal complex protein 3 (SYCP3) and then enter meiosis. WHAT IS KNOWN ALREADY: The recent reports of OSCs in the ovaries of non-menopausal and menopausal women suggest that neo-oogenesis is inducible during ovarian senescence. However, several questions remain regarding the isolation of these cells, their spontaneous maturation in vitro, and the final differentiation state of the resulting putative oocytes. STUDY DESIGN, SIZE, DURATION: DDX4-positive OSCs were obtained from 19 menopausal and 13 non-menopausal women (who underwent hysterectomy for uterine fibroma, ovarian cyst, or other benign pathologies) and cultured for up to 3 weeks. Large and small cells were individually isolated and typed for early and late differentiation markers. PARTICIPANTS/MATERIALS, SETTING, METHODS: Ovarian cortex fragments were processed by immuno-magnetic separation using a rabbit anti-human DDX4 antibody and the positive populations were measured by assessing both FRAGILIS and stage-specific embryonic antigen 4 (SSEA-4) expression. After 3 weeks in culture, large oocyte-like cells were individually isolated by DEPArray based on PKH26 red staining and cell size determination. GDF-9 and SYCP3 as final, and developmental pluripotency-associated protein 3 (DPPA3) as primordial, germline markers were measured by droplet digital PCR. The haploid versus diploid chromosomal content of chromosomes X and 5 was investigated using fluorescence in situ hybridization (FISH). MAIN RESULTS AND THE ROLE OF CHANCE: SSEA-4+ and FRAGILIS+ subsets of DDX4-positive populations were present at lower mean levels in menopausal (SSEA-4+: 46.7%; FRAGILIS+: 47.5%) than in non-menopausal (SSEA-4+: 64.9%; FRAGILIS+: 64.8) women (P < 0.05). A comparison of the women's age with the ratio of DDX4-positive cells/cm3 of ovarian cortex revealed an inverse correlation with OSC number (P < 0.05). Once cultured, cells from both groups differentiated to form large (up to 80 μm) mature oocyte-like cells with typical oocyte morphology. Despite the higher numbers of these cells in cultures from non-menopausal women (37.4 versus 23.7/well; P < 0.001), the intra-culture percentages of large oocyte-like cells did not differ significantly between the two groups. Single large oocyte-like cells isolated from non-menopausal and menopausal women expressed equivalent levels of GDF-9 (e.g. 2.0 and 2.6 copies/μl RNA, respectively) and SYCP3 (e.g. 1.2 and 1.5 copies/μl RNA, respectively) mRNA. The remaining small cells isolated from the cultures expressed large amounts of DPPA3 mRNA (e.g. 5.0 and 5.1 copies/μl RNA, from menopausal and non-menopausal women, respectively), which was undetectable in the large oocyte-like cells. FISH analysis of the large and small cells using probes for chromosomes X and 5 revealed a single signal in the large cells, indicative of chromosome haploidy, whereas in the small cells two distinct signals for each chromosome indicated diploidy. LARGE SCALE DATA: Not applicable. LIMITATIONS, REASONS FOR CAUTION: Our study demonstrated the final differentiation of OSCs, collected from the ovarian cortex of adult women, to oocyte-like cells. However, because the rate of differentiation was low, a major role of the stem cell niche housing these OSCs cannot be ruled out. WIDER IMPLICATIONS OF THE FINDINGS: Since the ability of OSCs to generate mature oocytes in vitro is highly variable, the viability of these cells in the ovarian cortex of non-menopausal and menopausal women may well be determined by the stem cell niche and the woman's concurrent reproductive state. Our study showed that the oocyte-like cells obtained by OSC differentiation in vitro, including those from the OSCs of menopausal women, express markers of meiosis. This model of ovarian neo-oogenesis will contribute to the development of approaches to treat female infertility. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by Italian Association for Cancer Research (IG grant 17536), and from the Apulia Region ('Oncogenomic Project' and 'Jonico-Salentino Project'). All Authors declare no competing interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Silvestris E, Cafforio P, D'Oronzo S, et al. In vitro differentiation of human oocyte-like cells from oogonial stem cells: single-cell isolation and molecular characterization. Hum Reprod. 2018. PMID: 29304224. doi:10.1093/humrep/dex377

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。